Protecting Participants in Bioequivalence Studies for Abbreviated New Drug Applications During the COVID-19 Public Health Emergency January 15, 2021 Auto Bot News 0 This guidance is being issued to address the Coronavirus Disease 2019 (COVID-19) public health emergency.
